Landry Benjamin 4

What Happened

• Landry Benjamin, General Counsel of Health Catalyst, was granted a total of 305,473 contingent equity awards on Feb 25, 2026: 289,000 restricted stock units (RSUs) and 16,473 performance-based restricted stock units (PRSUs). These awards were granted at $0.00 per share (they are contingent rights to receive common stock).
• On Feb 26, 2026, 6,317 shares were disposed of at $1.75 per share (totaling $11,041). That sale was a mandated "sell to cover" to satisfy tax withholding obligations and not a discretionary open-market sale.

Key Details

• Transaction dates: Awards recorded 2026-02-25; sell-to-cover occurred 2026-02-26. Form 4 filed 2026-02-27 (timely).
• Award amounts: 289,000 RSUs (F1) and 16,473 PRSUs (F2) — total 305,473 contingent units.
• Sale details (tax withholding): 6,317 shares sold at $1.75 each for $11,041 (F3). This sale was to cover tax withholding tied to RSU vesting.
• Vesting: RSUs vest in 12 equal quarterly installments beginning March 1, 2026 (per F1). PRSUs are performance-contingent based on FY2025 results (per F2).
• Shares owned after transaction: Not specified in this filing.

Context

• RSUs and PRSUs are awards that convert to shares only if vesting and/or performance conditions are met; they are not the same as an open-market purchase (not necessarily a bullish signal).
• The 6,317-share disposal was a routine sell-to-cover for taxes mandated by the company’s equity plan, not an independent sale decision by the insider.
• Filing appears timely (reported within the typical two-business-day window).